Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...

By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African ...

Total solar eclipses are not just incredible celestial events. They are also important scientific moments that allow ...

The US Food and Drug Administration (FDA) has approved use of the vaccine Yeztugo, manufactured by Gilead Sciences, is an anti-HIV drug.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Immuno Cure Biotech Ltd. is collaborating with Pharmajet Inc. to evaluate the safety and immunogenicity of its HIV ...